BioCentury
ARTICLE | Company News

Laboratory Corp. of America Holdings sales and marketing update

August 30, 2010 7:00 AM UTC

LabCorp launched an in vitro genetic test to identify the presence of an interleukin-28B (IL-28B; IFNL3) polymorphism, which may help predict the response of HCV patients to peginterferon alpha-based...